However, the steroidal mineralocorticoid receptor antagonists cause hyperkalemia especially in diabetic patients and in those with decreased cardiac or renal function particularly when used in combination with RAAS blockers (RR 2.17, 95% CI 1.47-3.22) [55]. The gene discussed is NR3C2; the disease is Hyperkalemia.